Back to
Cetera Investment Advisers
LTRN3 quarters
Position history for
Cetera Investment Advisers's holdings in LANTERN PHARMA INC
Yes. Cetera Investment Advisers holds 12,228 shares of LTRN (Lantern Pharma), worth $50,991, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Cetera Investment Advisers has held LTRN since Q4 2025, across 3 quarterly 13F filings.
Current Value
$50,991
Current Shares
12,228
Total Value Change
+$13,940
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC